Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer

NCT03088124 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Low Risk Prostate Cancer

Interventions

DRUG: Apalutamide

Sponsor

Institut Paoli-Calmettes

Collaborators

[object Object]